Related Experiment Video

Updated: May 24, 2026

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

Chronic myeloid leukemia and risk of second malignancy in two eras of treatment

Brady L Stein1

  • 1Division of Hematology/Oncology, Department of Medicine, Northwestern Feinberg University School of Medicine, Chicago, IL 60611, USA. brady-stein@northwestern.edu

Leukemia & Lymphoma
|February 25, 2012
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Detecting Anastasis In Vivo by CaspaseTracker Biosensor20:16

Detecting Anastasis In Vivo by CaspaseTracker Biosensor

Published on: February 1, 2018

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...